Highlights
-
•
First Scandinavian sepsis cases from Ignatzschineria indica, Ignatzschineria ureiclastica, Wohlfahrtiimonas chitiniclastica.
-
•
Calliphora and Lucilia blowflies are vectors for I. indica, I. ureiclastica, W. chitiniclastica.
-
•
W. magnifica spreads W. chitiniclastica in warmer climates, but not in Scandinavia.
-
•
MALDI-TOF and genome sequencing confirmed I. indica, I. ureiclastica, W. chitiniclastica.
-
•
Targeted antibiotics led to recovery from I. indica, I. ureiclastica, and W. chitiniclastica sepsis.
Keywords: Myiasis, Fly larvae, Calliphoridae, Lucilia, Septicaemia, Emerging pathogen
Abstract
We present the first Scandinavian cases of bacteremia caused by Ignatzschineria indica, I. ureiclastica, and Wohlfahrtiimonas chitiniclastica. Two patients with fly larvae-infested wounds were admitted to a Danish hospital in the summer of 2024. The first patient, a 62-year-old male with alcohol overuse and septic shock, had W. chitiniclastica and I. ureiclastica bacteremia, managed with piperacillin/tazobactam and ciprofloxacin. The second, a 67-year-old diabetic male with peripheral vascular disease, had I. indica bacteremia requiring below-knee amputation and targeted antibiotics. Both isolates were identified via MALDI-TOF mass spectrometry and whole-genome sequencing, with antibiotic “susceptibility testing” guiding therapy. Despite severe presentations, both patients survived. These cases highlight the emergence of these pathogens in Northern Europe and reinforce the importance of advanced diagnostics and personalized treatment strategies in myiasis-associated sepsis.
Graphical abstract
Introduction
Ignatzschineria species and Wohlfahrtiimonas chitiniclastica are gut bacteria that in Denmark are known to originate from the larvae of flies in the family Calliphoridae (blowflies, e.g., Calliphora and Lucilia spp.). These bacteria have also been detected in various environmental sources and foods, e.g., in frozen chicken meat and in chicken meat samples obtained from retail markets [1]. Human infections are rare, mostly in patients with chronic wounds, poor hygiene, or comorbidities. Symptoms vary from asymptomatic local infections to severe systemic disease, including bacteremia and osteomyelitis [2]. Increasing reports of these pathogens globally, particularly in association with wound myiasis but also in patients without myiasis, underscore the need for clinical awareness and accurate identification [3].
Case reports
Patient 1
A 62-year-old man admitted in August 2024 was found unresponsive at home with widespread fly larvae-infested wounds. He lived in unsanitary conditions, had a history of alcohol overuse, no known comorbidities, and was likely unconscious for 24-48 hours before discovery. On admission to Zealand University Hospital, Nykøbing F, examination revealed extensive cellulitis and larval infestation of his lower extremities. Prehospital vitals confirmed septic shock (systolic blood pressure 75-95 mmHg, pulse >150, respiratory rate 21-49, SpO2 75-97%). Initial labs: C-reactive protein (CRP) 220 mg/l (ref <5), white blood cell count (WBC) 29.5 × 10⁹/l (ref 3.5-8.8), lactate 3.7 mmol/l, and rhabdomyolysis (creatin kinase 1100 U/l). Blood cultures grew gram-negative rods in one aerobic bottle (day 2), and W. chitiniclastica was identified by MALDI-TOF the same day. The next day, Ignatzschineria ureiclastica was identified from an anaerobic bottle. Two wound swabs grew Staphylococcus aureus. The patient received IV piperacillin/tazobactam (4 g every 8 hours), continued based on clinical response and susceptibility. Due to worsening, ciprofloxacin (500 mg every 12 hours) was added on day 5. Antibiotics were given for 11 days; no further surgery was required.
Patient 2
A 67-year-old man with type II diabetes, peripheral vascular disease, recurrent pressure ulcers, a left below-the-knee amputation, and a recent right metatarsal amputation was admitted to Zealand University Hospital, Nykøbing, in September 2024 for an infected wound on his amputated right foot. He lived in a poorly ventilated environment with irregular wound care and reported seeing a fly larva fall from the wound. On arrival, labs showed CRP 210 mg/l (ref <5) and WBC 174.7 × 10⁹/l (ref 3.5-8.8). Blood cultures grew gram-negative rods in one aerobic bottle on day 2, and Ignatzschineria indica was identified by MALDI-TOF on day 3. Wound swab grew S. aureus. Empirical treatment with benzylpenicillin and cloxacillin was started on days 1-2, changed to piperacillin and cloxacillin on days 2-4 after finding gram-negative rods, and then switched to ciprofloxacin for 6 days based on antibiotic susceptibility testing. Due to infection and initial refusal of further amputation, a wound revision was performed on day 2, followed by a right, below-the-knee amputation on day 10.
Both patients responded well to antibiotic therapy, with resolution of symptoms and gradual wound healing. They were discharged to rehabilitation units for outpatient follow-up at 3 weeks, where both were recovering satisfactorily.
Methods
Blood cultures (two aerobic, one anaerobic bottle) were performed using the Bact/Alert system. Cultures were grown on 5% blood agar, and isolates were identified using MALDI-TOF mass spectrometry (Bruker). MALDI-TOF was performed on a 3-hour culture and subsequently on an overnight culture. Antibiotic susceptibility testing followed EUCAST guidelines; however, no breakpoints exist for either Wohlfartiimonas or Ignatzschineria spp. Zones are reported in the Table 1. Whole-genome sequencing (WGS) was performed on the GridION platform (Oxford Nanopore Technologies) for confirmation of the identification and genome-based resistance gene profiling (Table 1). DNA extraction used PowerBead tubes (Qiagen), purification with AMPure XP beads (Beckman Coulter), and quantification by Qubit dsDNA Broad Range assay (Thermo Fisher Scientific). Libraries were prepared with the SQK-RBK114.24 kit. The fly species in Patient 1 was identified by Professor Thomas Pape of The Natural History Museum, Copenhagen, using photos from prehospital staff. The larvae belonged to Calliphora or Lucilia, both common blow flies whose larvae are known to carry Ignatzschineria and Wohlfahrtiimonas [1,4]. It was believed to be Lucilia, as a few Lucilia flies were seen in one of the photos.
Table 1.
Phenotypic resistance and resistance genes detected in the 3 isolates from patients 1 and 2.
| Antibiotic |
Isolate 1 |
Isolate 2 |
Isolate 3 |
|||
|---|---|---|---|---|---|---|
| Patient no. 1 |
Patient no. 1 |
Patient no. 2 |
||||
|
Wohlfahrtiimonas chitiniclastica |
Ignatzschineria ureiclastica |
Ignatzschineria indica |
||||
| Eucast zone, mm | Wgs resistance gene detected | Eucast zone, mm | Wgs resistance gene detected | Eucast zone, mm | Wgs resistance gene detected | |
| Ampicillin | 19 | - | 28 | - | 30 | - |
| Piperacillin/tazobactam | 34 | - | 26 | - | 15 | - |
| Gentamicin | 20 | APH(6)-Id, APH(3′)-Ib, APH(3′)-1a, AAC(6)-Ib4 | 24 | - | 17 | APH(6)-Id, APH(3′)-Ib, AadA14 |
| Ciprofloxacin | 34 | - | 34 | - | 29 | - |
| Cefpodoxim | 33 | - | 31 | - | 22 | - |
| Amoxicillin/clavulanic acid | 28 | - | 29 | - | 30 | - |
| Mecillinam | 24 | - | 18 | - | 16 | - |
| Meropenem | 41 | OXA-1 | 34 | - | 30 | - |
| Ceftazidim | 30 | - | 6 | - | 15 | - |
| Tobramycin | 13 | APH(6)-Id, APH(3)-Ib, AAC(6)-Ib4 | nd | - | 12 | APH(6)-Id, APH(3)-Ib, AadA14 |
| Sulfamethoxazole/trimetoprim | nd | Sul2, dfrA1 | nd | - | 10 | Sul2, Dfrl |
| Tetracycline | nd | Tet(H), msrE | nd | - | nd | Tet(H) |
| Macrolide | nd | mphE | nd | - | nd | - |
| Lincosamide | nd | - | nd | - | nd | lnuG |
nd: not determined; Wgs: whole genome sequencing.
Discussion
This is the first report of bacteremia caused by Ignatzschineria species and W. chitiniclastica in Scandinavia. Both patients had significant risk factors, including chronic wounds, poor hygiene, and comorbidities, consistent with previously reported cases [5,6].
W. chitiniclastica and Ignatzschineria spp. are emerging pathogens in wound myiasis, particularly in patients with compromised skin integrity [1,6]. Infections can range from localized wound infections to severe sepsis and, in rare cases, endocarditis or osteomyelitis [7,8]. Previously, these bacteria were thought to be transmitted mainly by the flesh fly Wohlfahrtia magnifica, which is a species that does not occur in Scandinavia. However, W. chitiniclastica and Ignatzschineria spp. are also gut bacteria of blowflies of the genera Calliphora (blue bottle flies) and Lucilia (green bottle flies), which can cause myiasis in temperate regions. Cases of myiasis with W. chitiniclastica have been reported in Estonia, as well as the United Kingdom, France, Spain, Hungary, Turkey, Egypt, Iran, Korea, the United States of America, and South America [5,6,[9], [10], [11], [12]]. For species of Ignatzschineria, human cases have been documented in Slovenia, Canada, France, and other European countries [2,[10], [11], [12], [13]]
In both cases, prompt identification of the pathogens allowed for targeted antibiotics and surgical management. Advanced diagnostic tools, such as MALDI-TOF MS and WGS, are essential for accurate identification of these organisms [6]. Both W. chitiniclastica and Ignatzschineria spp. generally show broad susceptibility to antibiotics, with varying resistance patterns, necessitating susceptibility testing to guide therapy [6,8,14]). Ignatzschineria spp. demonstrate susceptibility to aminoglycosides (amikacin, gentamicin), fluoroquinolones (ciprofloxacin), and β-lactams, but carbapenem resistance has been reported in specific cases [7,8,14]. W. chitiniclastica have previously been treated with β-lactams (e.g., ceftazidime, ceftriaxone), fluoroquinolones (levofloxacin), or trimethoprim/sulfamethoxazole, though intrinsic resistance to fosfomycin and emerging resistance to aminoglycosides is noted in some strains [2]. In our isolates, we found an OXA-1 gene, a class D β-lactamse gene, in the W. chitiniclastica, which is unusual, but phenotypic testing showed a large zone for meropenem. The Ignatzschineria indica had a small zone for piperacillin/tazobactam, indicating resistance, which is why therapy was changed to ciprofloxacin.
Both patients responded well to treatment. These cases highlight the need to include these rare bacteria in sepsis differentials for patients with myiasis or chronically infested wounds. Further research is needed to better understand the epidemiology, pathogenesis, and optimal treatment strategies for these rare infections.
Conclusion
We present the first Scandinavian cases of bacteremia caused by Ignatzschineria species and W. chitiniclastica linked to fly larvae-infested wounds. These cases emphasize the importance of considering these emerging pathogens in myiasis-associated sepsis and the need for accurate diagnostics and targeted antibiotic therapy.
Declaration of competing interest
The authors have no competing interests to declare.
Acknowledgments
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Ethical approval statement
The case report was conducted in accordance with the Declaration of Helsinki. Ethical approval and written informed consent were obtained from the patient for the publication of clinical details and accompanying images.
Author contributions
RJC assisted in clinical management and data collection and drafted the first version of the manuscript. CM obtained ethical approval and informed consent, assisted in data collection, and contributed to manuscript preparation. ALL assisted with microbiological analyses and contributed to manuscript preparation. WC and JFM were responsible for clinical management of the patients and contributed to manuscript preparation. ALE and MK performed and interpreted the microbiological analyses, advised on antimicrobial treatment, and contributed to manuscript preparation.
All authors approved the manuscript and agreed to be accountable for all aspects of the work in ensuring that any questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Declaration of AI-assisted technologies in the preparation of the graphical abstract
The image used in the graphical abstract for this article was generated partly by AI using the tool “Perplexity AI.”
References
- 1.Tóth E.M., Schumann P., Borsodi A.K., Kéki Z., Kovács A.L., Márialigeti K. Wohlfahrtiimonas chitiniclastica gen. nov., sp. nov., a new gammaproteobacterium isolated from Wohlfahrtia magnifica (Diptera: Sarcophagidae) Int J Syst Evol Microbiol. 2008;58:976–981. doi: 10.1099/ijs.0.65324-0. [DOI] [PubMed] [Google Scholar]
- 2.Gupta A.K., Dharne M.S., Rangrez A.Y., Verma P., Ghate H V, Rohde M., et al. Ignatzschineria indica sp. nov. and Ignatzschineria ureiclastica sp. nov., isolated from adult flesh flies (Diptera: Sarcophagidae) Int J Syst Evol Microbiol. 2011;61:1360–1369. doi: 10.1099/ijs.0.018622-0. [DOI] [PubMed] [Google Scholar]
- 3.Barker H.S., Snyder J.W., Hicks A.B., Yanoviak S.P., Southern P., Dhakal B.K., et al. First case reports of Ignatzschineria (Schineria) indica associated with myiasis. J Clin Microbiol. 2014;52:4432–4434. doi: 10.1128/JCM.02183-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Iancu Lavinia, Necula-Petrareanu G., Purcarea C. Potential bacterial biomarkers for insect colonization in forensic cases: preliminary quantitative data on Wohlfahrtiimonas chitiniclastica and Ignatzschineria indica dynamics. Sci Rep. 2020;10:8497. doi: 10.1038/s41598-020-65471-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Campisi L., Mahobia N., Clayton JJ. Wohlfahrtiimonas chitiniclastica Bacteremia Associated with Myiasis, United Kingdom. Emerg Infect Dis. 2015;21:1068–1069. doi: 10.3201/eid2106.140007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Schröttner P., Rudolph W.W., Damme U., Lotz C., Jacobs E., Gunzer F. Wohlfahrtiimonas chitiniclastica: current insights into an emerging human pathogen. Epidemiol Infect. 2017;145:1292–1303. doi: 10.1017/S0950268816003411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lysaght T.B., Wooster M.E., Jenkins P.C., Koniaris LG. Myiasis-induced sepsis: a rare case report of Wohlfahrtiimonas chitiniclastica and Ignatzschineria indica bacteremia in the continental United States. Medicine. 2018;97 doi: 10.1097/MD.0000000000013627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Alexander J. Fenwick Vaneet Arora Julie Ribes. Wohlfahrtiimonas chitiniclastica: Two Clinical Cases and a Review of the Literature. Clin Microbiol Newsl. 2019;41:33–38. [Google Scholar]
- 9.de Dios A., Jacob S., Tayal A., Fisher M.A., Dingle T.C., Hamula CL. First report of Wohlfahrtiimonas chitiniclastica isolation from a patient with cellulitis in the United States. J Clin Microbiol. 2015;53:3942–3944. doi: 10.1128/JCM.01534-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Snyder S., Singh P., Goldman J. Emerging pathogens: a case of Wohlfahrtiimonas chitiniclastica and Ignatzschineria indica bacteremia. IDCases. 2020;19 doi: 10.1016/j.idcr.2020.e00723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Le Brun C., Gombert M., Robert S., Mercier E., Lanotte P. Association of necrotizing wounds colonized by maggots with Ignatzschineria-associated Septicemia. Emerg Infect Dis. 2015;21:1881–1883. doi: 10.3201/eid2110.150748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Fear T., Richert Q., Levesque J., Walkty A., Keynan Y. Ignatzschineria indica bloodstream infection associated with maggot infestation of a wound in a patient from Canada. J Assoc Med Microbiol Infect Dis Can. 2020;5:193–200. doi: 10.3138/jammi-2019-0027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nadrah K., Biškup U.G., Špik V.C., Premru M.M., Šoba B. Ignatzschineria larvae Bacteremia following Lucilia sp. Myiasis in an irregular migrant: a case report. Korean J Parasitol. 2021;59:159–165. doi: 10.3347/kjp.2021.59.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kopf A., Bunk B., Coldewey S.M., Gunzer F., Riedel T., Schröttner P. Identification and antibiotic profiling of Wohlfahrtiimonas chitiniclastica, an underestimated human pathogen. Front Microbiol. 2021;12 doi: 10.3389/fmicb.2021.712775. [DOI] [PMC free article] [PubMed] [Google Scholar]

